Alliance Discussion with John Crowley: An Innovative, Patient-Centered Approach to Rare Diseases
John Crowley, Chairman and CEO of Amicus Therapeutics, discussed his personal journey with rare disease research, developing novel treatments, centering patient advocacy, and overcoming innovation barriers.
More: Alliance Discussion with John Crowley: An Innovative, Patient-Centered Approach to Rare Diseases